Skip to main content
TipRanks
Go Ultimate75% OFF

Scott L Burrows Insider Profile

4 Followers

Scott L Burrows, CFO at Spyre Therapeutics, holds 79.76K shares in Spyre Therapeutics (Ticker: SYRE), holds 59.12K shares in Arcutis Biotherapeutics (Ticker: ARQT).

Scott L Burrows's Trading History

SYRE
Spyre Therapeutics
Oct 02, 2026CFOUninformative Buy362.50K$7.79M
ARQT
Arcutis Biotherapeutics
Mar 08, 2023CFOUninformative Sell4.44K$1.61M

You May Also Like

Scott L Burrows insider profile FAQ

What is the percentage of profitable transactions made by Scott L Burrows?
The percentage of profitable transactions made by Scott L Burrows is 25%.
What is the average return per transaction made by Scott L Burrows?
The average return per transaction made by Scott L Burrows is -102.30%.
What stocks does Scott L Burrows hold?
Scott L Burrows holds: SYRE, ARQT stocks.
What was Scott L Burrows’s latest transaction?
Scott L Burrows’s latest transaction was an Uninformative Buy of $362.50K.
What was Scott L Burrows's most profitable transaction?
Scott L Burrows’s most profitable transaction was an Informative Sell of SYRE stock on September 5, 2024. The return on the trade was 39.30%.
What is Scott L Burrows's role in Spyre Therapeutics?
Scott L Burrows's role in Spyre Therapeutics is CFO.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.

TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.